A significant discovery in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in various forms of malignancies, https://bookmarklethq.com/story21920864/mini-antibodies-reactivate-p53-the-promising-approach-for-cancer-treatment